RB in breast cancer: Differential effects in estrogen receptor-positive and estrogen receptor-negative disease

Cell Cycle

Volumn 9, Issue 23, 2010, Pages 4607-

  Musgrove, Elizabeth A ^a   Sutherland, Robert L ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR; PROTEIN P16; RETINOBLASTOMA PROTEIN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CELL CYCLE; CELL PROLIFERATION; DNA DAMAGE; ENZYME PHOSPHORYLATION; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; NOTE; TREATMENT RESPONSE;

EID: 78650123930     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.23.13889     Document Type: Note

References (9)

1. Buckley MF, et al. Oncogene 1993; 8:2127-33.
2. Bosco EE, et al. Cell Cycle 2007; 6:667-71.
3. Herschkowitz JI, et al. Breast Cancer Res 2008; 10:R75.
4. Jiang Z, et al. J Clin Invest 2010; 120:3296-309.
5. Borg A, et al. Cancer Res 1992; 52:2991-4.
6. Hui R, et al. Clin Cancer Res 2000; 6:2777-87.
7. Ertel A, et al. Cell Cycle 2010; 9:4153-63.
8. Musgrove EA, et al. Nat Rev Cancer 2009; 9:631-43.
9. Derenzini M, et al. Clin Cancer Res 2008; 14:2199-209.